Skip to main content

Advertisement

ADVERTISEMENT

News

News
09/13/2022
September 13, 2022 – HECHINGEN, Germany and CAESAREA, Israel – Bentley, a global leader in minimally invasive medical devices for vascular treatments based in the Medical Valley of Hechingen, has acquired the rights of the GoBack catheter...
September 13, 2022 – HECHINGEN, Germany and CAESAREA, Israel – Bentley, a global leader in minimally invasive medical devices for vascular treatments based in the Medical Valley of Hechingen, has acquired the rights of the GoBack catheter...
September 13, 2022 – HECHINGEN,...
09/13/2022
Vascular Disease Management
News
09/07/2022
HOUMA, LA - Cardiovascular Institute of the South (CIS) is the first in Louisiana to use the latest generation of Medtronic's self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut FX, designed to enhance ease-of-use...
HOUMA, LA - Cardiovascular Institute of the South (CIS) is the first in Louisiana to use the latest generation of Medtronic's self-expanding transcatheter aortic valve replacement (TAVR) system, the Evolut FX, designed to enhance ease-of-use...
HOUMA, LA - Cardiovascular...
09/07/2022
Vascular Disease Management

Advertisement

News
09/07/2022
Leiden University Medical Center joins global network of partners in the development of Philips Spectral Angio CT suite and its use in clinical research, bringing spectral CT imaging technology into an integrated hybrid angio CT suite with...
Leiden University Medical Center joins global network of partners in the development of Philips Spectral Angio CT suite and its use in clinical research, bringing spectral CT imaging technology into an integrated hybrid angio CT suite with...
Leiden University Medical...
09/07/2022
Vascular Disease Management
News
09/07/2022
[REIMS, FRANCE – September 7, 2022] BCV announces a major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment – the GECKO System. The first-in-human case was conducted by Michel Piotin, MD, PhD,...
[REIMS, FRANCE – September 7, 2022] BCV announces a major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment – the GECKO System. The first-in-human case was conducted by Michel Piotin, MD, PhD,...
[REIMS, FRANCE – September 7,...
09/07/2022
Vascular Disease Management
News
09/06/2022
A program of patient education plus individualized nurse performance feedback and coaching can significantly reduce the amount of missed or refused doses of VTE-preventing drugs.
A program of patient education plus individualized nurse performance feedback and coaching can significantly reduce the amount of missed or refused doses of VTE-preventing drugs.
A program of patient education...
09/06/2022
Cath Lab Digest

Advertisement

News
09/01/2022
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an automated RV/LV ratio algorithm, a seamless new component of...
Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for an automated RV/LV ratio algorithm, a seamless new component of...
Viz.ai, the leader in AI-powered...
09/01/2022
Cath Lab Digest
News
08/26/2022
A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a...
A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a...
A three-drug medication known as...
08/26/2022
Cath Lab Digest
News
08/25/2022
Initial INSIGHT Registry data demonstrated RED® reperfusion catheters were highly effective in removing all clot types with an impressive 68.9% mTICI > 2b-3 overall first pass effect rate.
Initial INSIGHT Registry data demonstrated RED® reperfusion catheters were highly effective in removing all clot types with an impressive 68.9% mTICI > 2b-3 overall first pass effect rate.
Initial INSIGHT Registry data...
08/25/2022
Cath Lab Digest

Advertisement

News
08/24/2022
MK-2060 is a novel inhibitor of Factor XI being investigated for the prevention of thrombosis in patients with end-stage renal disease (ESRD). MK-2060, administered intravenously, is designed to work through a dual mechanism of action both...
MK-2060 is a novel inhibitor of Factor XI being investigated for the prevention of thrombosis in patients with end-stage renal disease (ESRD). MK-2060, administered intravenously, is designed to work through a dual mechanism of action both...
MK-2060 is a novel inhibitor of...
08/24/2022
Cath Lab Digest
News
08/18/2022
Motion analysis of video recorded on a smartphone accurately detected narrowed arteries in the neck, which are a risk factor for stroke.
Motion analysis of video recorded on a smartphone accurately detected narrowed arteries in the neck, which are a risk factor for stroke.
Motion analysis of video...
08/18/2022
Cath Lab Digest

Advertisement